CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C01604 | BRD-A66794241 | L-744832 | -- | -- | -- | Details |
| C01605 | BRD-A66846505 | BRD-A66846505 | -- | -- | -- | Details |
| C01606 | BRD-A66861218 | BRD-A66861218 | -- | -- | -- | Details |
| C01607 | BRD-A66920069 | fenigam | GABBR1; GABBR2 | GABA receptor agonist | -- | Details |
| C01608 | BRD-A66927094 | nemonapride | DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |
| C01609 | BRD-A67060370 | albendazole-oxide | -- | -- | -- | Details |
| C01610 | BRD-A67097164 | ifosfamide | CYP2A6; CYP3A7; CYP2B6; CYP2C19; CYP2C8; CYP2C9; CYP2C18; CYP3A4; CYP3A5; PTGS1 | DNA alkylating agent | -- | Details |
| C01611 | BRD-A67182178 | toloxatone | -- | -- | -- | Details |
| C01612 | BRD-A67254212 | BRD-A67254212 | -- | -- | -- | Details |
| C01613 | BRD-A67306036 | BRD-A67306036 | -- | -- | -- | Details |
| C01614 | BRD-A67373739 | AICA-ribonucleotide | PRKAA1 | AMPK activator | aica-ribonucleotide | Details |
| C01615 | BRD-A67433117 | NCS-382 | GABBR1; SLC52A2; GABBR2 | GABA receptor antagonist | -- | Details |
| C01616 | BRD-A67438293 | treprostinil | PTGIR | Prostacyclin analog | -- | Details |
| C01617 | BRD-A67479912 | progesterone | CYP17A1; NR3C2; PGR | Progesterone receptor agonist | -- | Details |
| C01618 | BRD-A67482312 | 4-P-PDOT | MTNR1B | Melatonin receptor antagonist | -- | Details |
| C01619 | BRD-A67508925 | BRD-A67508925 | -- | -- | -- | Details |
| C01620 | BRD-A67514145 | furaltadone | -- | -- | -- | Details |
| C01621 | BRD-A67516570 | lafutidine | HRH2 | Histamine receptor antagonist | -- | Details |
| C01622 | BRD-A67518171 | BRD-A67518171 | -- | -- | -- | Details |
| C01623 | BRD-A67521865 | BRD-A67521865 | -- | -- | -- | Details |
| C01624 | BRD-A67552019 | BRD-A67552019 | -- | -- | -- | Details |
| C01625 | BRD-A67552655 | etomoxir | CPT1A | Carnitine palmitoyltransferase inhibitor | -- | Details |
| C01626 | BRD-A67605442 | tetrahydrobiopterin | PAH; TH | Nitric oxide stimulant; Nitric oxide synthase stimulant; Phenylalanine 4-hydroxylase stimulant | -- | Details |
| C01627 | BRD-A67616246 | levomequitazine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01628 | BRD-A67697194 | BRD-A67697194 | -- | -- | -- | Details |
| C01629 | BRD-A67709388 | antimycin-a | CYCS | ATP synthase inhibitor | -- | Details |
| C01630 | BRD-A67748489 | K-858 | KIF11 | Kinesin-like spindle protein inhibitor | K-3644 | Details |
| C01631 | BRD-A67787745 | BRD-A67787745 | -- | -- | -- | Details |
| C01632 | BRD-A67788537 | salermide | SIRT2; SIRT1 | SIRT inhibitor | -- | Details |
| C01633 | BRD-A67799922 | phenoxybenzamine | ADRA2B | Adrenergic receptor antagonist | -- | Details |
| C01634 | BRD-A67862938 | naftidrofuryl | -- | -- | -- | Details |
| C01635 | BRD-A67975844 | NSC-405020 | MMP1 | Matrix metalloprotease inhibitor | -- | Details |
| C01636 | BRD-A67981824 | cefotaxime | -- | -- | -- | Details |
| C01637 | BRD-A68009927 | daunorubicin | TOP2A | RNA synthesis inhibitor; Topoisomerase inhibitor | -- | Details |
| C01638 | BRD-A68039575 | BRD-A68039575 | -- | -- | liquiritigenin | Details |
| C01639 | BRD-A68045637 | kepone | -- | -- | -- | Details |
| C01640 | BRD-A68061604 | BRD-A68061604 | -- | -- | -- | Details |
| C01641 | BRD-A68065211 | BRD-A68065211 | -- | -- | -- | Details |
| C01642 | BRD-A68083442 | pranidipine | CACNA1C | Calcium channel blocker | -- | Details |
| C01643 | BRD-A68123879 | BRD-A68123879 | -- | -- | -- | Details |
| C01644 | BRD-A68175400 | BRD-A68175400 | -- | -- | -- | Details |
| C01645 | BRD-A68202111 | BRD-A68202111 | -- | -- | -- | Details |
| C01646 | BRD-A68258842 | BRD-A68258842 | -- | -- | -- | Details |
| C01647 | BRD-A68274214 | BRD-A68274214 | -- | -- | -- | Details |
| C01648 | BRD-A68281735 | REV-5901 | ALOX5 | Lipoxygenase inhibitor; Leukotriene receptor antagonist | -- | Details |
| C01649 | BRD-A68304895 | BTS-54505 | SLC6A2; SLC6A3; SLC6A4 | Dopamine reuptake inhibitor; Serotonin reuptake inhibitor; Norepinephrine reputake inhibitor; Adrenergic transmitter uptake inhibitor | -- | Details |
| C01650 | BRD-A68318914 | 5-methylhydantoin | -- | -- | 5-METHYLHYDANTOIN | Details |
| C01651 | BRD-A68323834 | BRD-A68323834 | -- | -- | -- | Details |
| C01652 | BRD-A68397902 | VU-0415535-1 | -- | -- | -- | Details |
| C01653 | BRD-A68427178 | BRD-A68427178 | -- | -- | -- | Details |
| C01654 | BRD-A68464583 | mazindol | SLC6A2; SLC6A3; SLC6A4 | Dopamine reuptake inhibitor; Serotonin reuptake inhibitor | -- | Details |
| C01655 | BRD-A68493689 | simeprevir | CYP1A2; CYP3A4 | HCV inhibitor | -- | Details |
| C01656 | BRD-A68526335 | BRD-A68526335 | -- | -- | -- | Details |
| C01657 | BRD-A68537732 | doxifluridine | TYMS | Thymidylate synthase inhibitor | -- | Details |
| C01658 | BRD-A68589262 | troxipide | -- | -- | -- | Details |
| C01659 | BRD-A68631409 | evodiamine | TRPV1 | TRPV agonist; ATPase inhibitor | -- | Details |
| C01660 | BRD-A68650781 | epitiostanol | AR | Androgen receptor agonist | -- | Details |
| C01661 | BRD-A68721828 | BRD-A68721828 | -- | -- | -- | Details |
| C01662 | BRD-A68723818 | brompheniramine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01663 | BRD-A68739437 | NPK76-II-72-1 | -- | -- | -- | Details |
| C01664 | BRD-A68797623 | BRD-A68797623 | -- | -- | -- | Details |
| C01665 | BRD-A68802837 | BRD-A68802837 | -- | -- | -- | Details |
| C01666 | BRD-A68820570 | BRD-A68820570 | -- | -- | -- | Details |
| C01667 | BRD-A68842442 | BRD-A68842442 | -- | -- | -- | Details |
| C01668 | BRD-A68865339 | BRD-A68865339 | -- | -- | -- | Details |
| C01669 | BRD-A68888262 | azelastine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01670 | BRD-A68890828 | BRD-A68890828 | -- | -- | -- | Details |
| C01671 | BRD-A68891053 | BW-B70C | ALOX5 | Lipoxygenase inhibitor | -- | Details |
| C01672 | BRD-A68913459 | BRD-A68913459 | -- | -- | -- | Details |
| C01673 | BRD-A68929948 | DAPT-GSI-IX | -- | -- | -- | Details |
| C01674 | BRD-A68930007 | ouabain | ATP1A1 | ATPase inhibitor | -- | Details |
| C01675 | BRD-A68942014 | amitifadine | SLC6A2; SLC6A3; SLC6A4 | SERT inhibitor | -- | Details |
| C01676 | BRD-A68949340 | BRD-A68949340 | -- | -- | -- | Details |
| C01677 | BRD-A69097282 | BRD-A69097282 | -- | -- | -- | Details |
| C01678 | BRD-A69110666 | BRD-A69110666 | -- | -- | -- | Details |
| C01679 | BRD-A69110668 | BRD-A69110668 | -- | -- | -- | Details |
| C01680 | BRD-A69127847 | BRD-A69127847 | -- | -- | -- | Details |
| C01681 | BRD-A69196860 | BRD-A69196860 | -- | -- | -- | Details |
| C01682 | BRD-A69275535 | pinitol | -- | -- | -- | Details |
| C01683 | BRD-A69336132 | KM-04501 | -- | -- | -- | Details |
| C01684 | BRD-A69383366 | BRD-A69383366 | -- | -- | -- | Details |
| C01685 | BRD-A69407661 | 646_0226_7557 | -- | -- | -- | Details |
| C01686 | BRD-A69421747 | BRD-A69421747 | -- | -- | -- | Details |
| C01687 | BRD-A69429454 | BRD-A69429454 | -- | -- | -- | Details |
| C01688 | BRD-A69439373 | ST-003833 | -- | -- | -- | Details |
| C01689 | BRD-A69454249 | BRD-A69454249 | -- | -- | -- | Details |
| C01690 | BRD-A69470004 | BRD-A69470004 | XIAP | XIAP inhibitor | -- | Details |
| C01691 | BRD-A69512159 | carbidopa | DDC | Aromatic L-amino acid decarboxylase inhibitor | -- | Details |
| C01692 | BRD-A69563582 | BRD-A69563582 | -- | -- | -- | Details |
| C01693 | BRD-A69592287 | oxetane | -- | -- | -- | Details |
| C01694 | BRD-A69636825 | diltiazem | CACNA1C | Calcium channel blocker | -- | Details |
| C01695 | BRD-A69648159 | BRD-A69648159 | -- | -- | -- | Details |
| C01696 | BRD-A69651145 | minocycline | -- | -- | -- | Details |
| C01697 | BRD-A69777949 | flumequine | -- | -- | -- | Details |
| C01698 | BRD-A69786436 | BRD-A69786436 | -- | -- | -- | Details |
| C01699 | BRD-A69815203 | cyclosporin-a | PPIA; PPP3CA | Calcineurin inhibitor | -- | Details |
| C01700 | BRD-A69826632 | BRD-A69826632 | -- | -- | -- | Details |
| C01701 | BRD-A69917777 | aminopentamide | CHRM1 | Acetylcholine receptor antagonist | -- | Details |
| C01702 | BRD-A69927616 | isradipine | CACNA1C; CACNA1D; CACNA1F; CACNA1S; CACNA2D1 | Calcium channel blocker | -- | Details |
| C01703 | BRD-A69950438 | BRD-A69950438 | -- | -- | -- | Details |